Viewing Study NCT05423769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-06-04 @ 5:50 PM
Study NCT ID: NCT05423769
Status: COMPLETED
Last Update Posted: 2024-08-23
First Post: 2022-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
Sponsor: Hikma Pharmaceuticals LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing-Remitting Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fingolimod View
None Generic Fingolimod View
None Nervous System View
None Multiple Sclerosis View
None Relapsing-Remitting Multiple Sclerosis View
None Cohort Study View
None Observational Study View
None Effectiveness View
None Safety View
None Disease Modifying Treatments View